Assessment of the dicentric chromosome assay as a biodosimetry tool for more personalized medicine in a case of a high risk neuroblastoma 131 I-mIBG treatment

1. Chimeno, J.M.
2. Sebastià, N.
3. Torres-Espallardo, I.
4. Balaguer, J.
5. Candela-Juan, C.
6. Loaiza, J.L.
7. Adria, M.
8. Ibanez-Rosello, B.
9. Cañete, A.
10. Martí-Bonmatí, L.
11. Montoro, A.